DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Menu 返回 Poster-Presentations-Details

P211: Drug Shortages in Saudi Arabia: A Cross-Sectional Study





Poster Presenter

      Majdi Al Gharsan

      • Director, Director of Medical Services
      • Ministry of Defence
        Saudi Arabia

Objectives

Drug shortage is defined as a situation in which the total supply of all clinically interchangeable versions of an FDA-regulated medicine is inadequate to meet the current or projected demand at the user level. The aim of this study was to evaluate the characteristics of drug shortages in Saudi Arab

Method

A cross-sectional survey was conducted to assess the characteristics of drug shortages in the southern region of Saudi Arabia for the duration between March and June 2022. Healthcare professionals who work at hospitals in Saudi Arabia were invited to participate in this study.

Results

This study involved 705 participants in total. Pharmacists made up around half of them (46.2 %). Around 76.3 % of them were aware that there were drug shortages. More than half of them (61.4 %) acknowledged that there is a drug shortage at their hospital on a daily to monthly basis. The majority of them (71.6 %) stated that generic drug shortages are a typical occurrence. Tablets and capsules are the most frequent dosage forms that face shortages, according to about 40 % of survey participants. Vitamins and supplements and antimicrobial agents (antibiotics-antivirals-antifungals) were the most often reported therapeutic areas that frequently encounter drug shortages, with 58.9 % and 45.5 %, respectively.

Conclusion

A common issue in Saudi Arabia's southern region is a shortage of drugs. The implementation of numerous preventive strategies is necessary to avoid drug shortages. To address any unanticipated drug shortage issues, healthcare professionals should receive more training on the usage of alternative drugs.

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。